NCT02086643

Brief Summary

The goal of this study is to determine the success rate of the retroclavicular approach for the anesthesia of the upper limb in the obese patient population (BMI ≥ 30 kg/m2)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at below P25 for phase_4

Timeline
Completed

Started Dec 2013

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 8, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 13, 2014

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
Last Updated

October 6, 2015

Status Verified

October 1, 2015

Enrollment Period

1.8 years

First QC Date

March 8, 2014

Last Update Submit

October 3, 2015

Conditions

Keywords

Infraclavicular blockBrachial PlexusRetroclavicular ApproachComplications of retroclavicular approachSuccess of retroclavicular approachObese PatientsObesity and Anesthesia

Outcome Measures

Primary Outcomes (1)

  • Surgery completion under regional block

    Success rate is defined as the completion of the intended surgery under regional anesthesia with retroclavicular block without the need for a rescue technique. These techniques are defined as: adding local anesthetic locally by surgeon, rescue intravenous narcotics in excess of 1 microgram per kilogram of patient weight, need for general anesthesia, rescue distal neural blockage by anesthesiologist. Patient sedation with midazolam 1 to 2 mg IV or propofol perfusion up to 50 mcg/kg/min is allowed for patient comfort during the surgery and is not considered a rescue technique.

    Success is defined at end of surgery for which block was done, generally within 1 to 3 hours after block is performed

Secondary Outcomes (12)

  • Sensitive block progression

    Assessed 10, 20 and 30 minutes after block completion

  • Motor Block Progression

    Assessed 10, 20, 30 minutes after the block

  • Technique duration

    Time required in seconds for the retroclavicular block technique completion, generally under 15 minutes

  • Needle visualization

    Assessed after study completion, once all 30 patients will have been completed. Assessment will take place in the first 4 weeks after all 30 patients have been recruited

  • Patient discomfort

    Assessed 1 minute after block completion

  • +7 more secondary outcomes

Study Arms (1)

Retroclavicular block

EXPERIMENTAL

Retroclavicular block

Procedure: Retroclavicular block

Interventions

Retroclavicular ultrasound guided nerve block with total injection of 40 ml of a mixture of 20 ml ropivacaine 0,5% (5 mg/ml) + 20 ml mepivacaine 1,5% (15 mg/ml) + epinephrine 1 : 400 000 (2,5 mcg/ml). Incremental injections of 5 ml separated by an aspiration test.

Retroclavicular block

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective or Urgent Surgery of the hand, wrist or forearm
  • years and older
  • Ability to consent
  • American Society of Anesthesiologists class 1 to 3
  • BMI ≥ 30 kg/m2

You may not qualify if:

  • Infection at the site of infection
  • Abnormal anatomy at the site of infection
  • Coagulopathy
  • Severe Pulmonary Disease
  • Preexisting neurological symptom(s) in the operated arm
  • Pregnant patients
  • Patients weighing less than 50 kg
  • Allergy to amide type local anesthetics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre hospitalier universitaire de Sherbrooke (CHUS)

Sherbrooke, Quebec, J1H 5N4, Canada

Location

MeSH Terms

Conditions

OverweightObesity

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Pablo Echave, M.D.

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Anesthesiologist

Study Record Dates

First Submitted

March 8, 2014

First Posted

March 13, 2014

Study Start

December 1, 2013

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

October 6, 2015

Record last verified: 2015-10

Locations